Connor, Clark & Lunn Investment Management Ltd. Charles River Laboratories International, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $26 Billion
- Q2 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 191,268 shares of CRL stock, worth $35.2 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
191,268
Previous 24,839
670.03%
Holding current value
$35.2 Million
Previous $3.74 Million
676.38%
% of portfolio
0.11%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding CRL
# of Institutions
618Shares Held
52.5MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.07 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$937 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$694 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$401 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$342 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.37B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...